Condition: Heart Failure · Left Ventricular Assist Device · Prognosis · Sponsor: Rigshospitalet, Denmark
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.
This description comes directly from the study's public registry record.
Kiran Mirza, MD · +4535451442 · KiranMirza@dadlnet.dk
Finn Gustafsson, MD, PhD, DMSci · +4535459743 · Finn.Gustafsson@regionh.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet | Copenhagen, DK, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04377854